Your English writing platform
Discover LudwigExact(2)
Therefore, CT ratings 1 and 2 were considered benign test results, and CT ratings 3 to 5 were considered malignant test results.
In both situations, an FDG-PET/CT rating of 1 was considered a benign test result, and FDG-PET/CT ratings of 2 4 were considered malignant test results.
Similar(58)
Malignant hyperthermia test was performed by placing Ryr1 +/+ and Ryr1 AG/+ mice in a 41°C humidified incubator for 30 min. There was no sign of muscle rigidity or spasticity or seizure activity for any of the animals.
Malignant hyperthermia test was performed by placing Ryr1 +/+ and Ryr1 AG/+ mice in a 41°C humidified incubator for 30 min. To test for sensitivity to halogenated anesthetics, stage 3 anesthetic isoflurane (∼5.5 × 10−5 ml/cm) was administered through a nasal cone to Ryr1 AG/+ mice at a maximum of 30 min exposure.
We assessed the capacity of the terms to discriminate between benign and malignant calcifications, testing them against radiologists' assessments of malignancy and follow-up data.
The lesions were subdivided into two groups (Table 1): training set (14 benign and 18 malignant) and testing set (8 benign and 8 malignant).
The lesions were subdivided into two groups: training set (14 benign and 18 malignant) and testing set (8 benign and 8 malignant).
The other two types of malignant tumor tested, ACC and MEC, demonstrated less methylation than SDC.
However, promoter hypermethylation was present in all malignant tumors tested (cases 6, 9, 13 and 14 presented in Figure 2a).
It is constant through all types of human malignant cells tested, including cells directly explanted from fresh tumors.
The specific band was detected in all ten samples of malignant ascites tested with each of three different target genes.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com